Sunbelt Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.79M | Buy |
40,395
+3
| +0% | +$665 | 0.55% | 34 |
|
|
2025
Q4 | $9.23M | Sell |
40,392
-182
| -0.4% | -$41.5K | 0.62% | 29 |
|
|
2025
Q3 | $9.39M | Sell |
40,574
-5,921
| -13% | -$1.21M | 0.65% | 27 |
|
|
2025
Q2 | $8.26M | Buy |
46,495
+6,013
| +15% | +$1.12M | 0.73% | 21 |
|
|
2025
Q1 | $8.48M | Sell |
40,482
-6,013
| -13% | -$1.17M | 0.76% | 20 |
|
|
2024
Q4 | $8.19M | Sell |
46,495
-116
| -0.2% | -$21.3K | 0.72% | 21 |
|
|
2024
Q3 | $9.2M | Sell |
46,611
-1,409
| -3% | -$263K | 0.9% | 14 |
|
|
2024
Q2 | $8.24M | Buy |
48,020
+1,622
| +3% | +$269K | 0.84% | 20 |
|
|
2024
Q1 | $8.45M | Sell |
46,398
-4,204
| -8% | -$725K | 0.94% | 16 |
|
|
2023
Q4 | $7.84M | Sell |
50,602
-864
| -2% | -$126K | 0.99% | 14 |
|
|
2023
Q3 | $7.67M | Buy |
51,466
+10,277
| +25% | +$1.51M | 1.06% | 13 |
|
|
2023
Q2 | $5.55M | Sell |
41,189
-2,346
| -5% | -$344K | 0.8% | 22 |
|
|
2023
Q1 | $6.87M | Buy |
43,535
+3,493
| +9% | +$534K | 1.11% | 13 |
|
|
2022
Q4 | $6.47M | Buy |
40,042
+213
| +0.5% | +$32.7K | 1.26% | 11 |
|
|
2022
Q3 | $5.34M | Buy |
39,829
+1,156
| +3% | +$166K | 1.13% | 13 |
|
|
2022
Q2 | $5.92M | Sell |
38,673
-1,549
| -4% | -$237K | 1.25% | 12 |
|
|
2022
Q1 | $6.59M | Sell |
40,222
-26,131
| -39% | -$3.8M | 1.21% | 13 |
|
|
2021
Q4 | $9.52M | Sell |
66,353
-4,795
| -7% | -$566K | 1.55% | 8 |
|
|
2021
Q3 | $8.36M | Hold |
71,148
| – | – | 1.5% | 9 |
|
|
2021
Q2 | $8.36M | Sell |
71,148
-263
| -0.4% | -$29.6K | 1.5% | 9 |
|
|
2021
Q1 | $7.73M | Sell |
71,411
-10,271
| -13% | -$1.1M | 1.52% | 6 |
|
|
2020
Q4 | $8.75M | Sell |
81,682
-5,496
| -6% | -$528K | 1.81% | 7 |
|
|
2020
Q3 | $8.1M | Buy |
87,178
+43,807
| +101% | +$4.12M | 2.25% | 5 |
|
|
2020
Q2 | $4.26M | Buy |
43,371
+1,203
| +3% | +$106K | 1.46% | 10 |
|
|
2020
Q1 | $3.21M | Sell |
42,168
-64,137
| -60% | -$5.46M | 0.14% | 75 |
|
|
2019
Q4 | $9.41M | Buy |
106,305
+4,175
| +4% | +$347K | 0.99% | 18 |
|
|
2019
Q3 | $7.73M | Buy |
102,130
+65,293
| +177% | +$4.48M | 0.87% | 20 |
|
|
2019
Q2 | $2.68M | Buy |
36,837
+702
| +2% | +$55.2K | 1.17% | 16 |
|
|
2019
Q1 | $2.91M | Buy |
36,135
+131
| +0.4% | +$10.7K | 1.46% | 13 |
|
|
2018
Q4 | $3.32M | Buy |
36,004
+1,224
| +4% | +$108K | 1.93% | 7 |
|
|
2018
Q3 | $3.29M | Sell |
34,780
-2,800
| -7% | -$266K | 1.76% | 8 |
|
|
2018
Q2 | $3.48M | Buy |
37,580
+21,824
| +139% | +$2.13M | 2.08% | 5 |
|
|
2018
Q1 | $1.49M | Sell |
15,756
-660
| -4% | -$72.5K | 1.36% | 15 |
|
|
2017
Q4 | $1.59M | Buy |
16,416
+936
| +6% | +$88.2K | 1.54% | 9 |
|
|
2017
Q3 | $1.38M | Buy |
15,480
+12,614
| +440% | +$960K | 1.45% | 10 |
|
|
2017
Q2 | $208K | Sell |
2,866
-378
| -12% | -$25.4K | 0.39% | 73 |
|
|
2017
Q1 | $211K | Hold |
3,244
| – | – | 0.32% | 84 |
|
|
2016
Q4 | $203K | Sell |
3,244
-120
| -4% | -$7.33K | 0.31% | 85 |
|
|
2016
Q3 | $212K | Hold |
3,364
| – | – | 0.26% | 94 |
|
|
2016
Q2 | $208K | Sell |
3,364
-175
| -5% | -$10.7K | 0.27% | 90 |
|
|
2016
Q1 | $202K | Hold |
3,539
| – | – | 0.29% | 84 |
|
|
2015
Q4 | $210K | Buy |
+3,539
| New | +$204K | 0.3% | 79 |
|
|
2015
Q3 | – | Sell |
-3,609
| Closed | -$242K | – | 114 |
|
|
2015
Q2 | $242K | Buy |
3,609
+164
| +5% | +$10.7K | 0.33% | 76 |
|
|
2015
Q1 | $202K | Sell |
3,445
-800
| -19% | -$48.3K | 0.3% | 92 |
|
|
2014
Q4 | $278K | Buy |
+4,245
| New | +$268K | 0.37% | 60 |
|
Other funds holding ABBV
VCM
VPM
Sunbelt Securities's ABBV Position: Q1 2026 in Review
Sunbelt Securities increased its AbbVie (ABBV) stake by 0.01% in Q1 2026, buying an estimated $665 and bringing the position to 40,395 shares worth $8.79M. The position accounts for 0.55% of the portfolio, ranked #34.
Sunbelt Securities first reported a position in ABBV in Q4 2014 and has held it in 45 quarters since. The position peaked at $9.52M in Q4 2021. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Sunbelt Securities held 40,395 shares of AbbVie worth $8.79M as of Q1 2026.
- Sunbelt Securities bought 3 AbbVie shares in Q1 2026, an estimated $665.
- AbbVie made up 0.55% of Sunbelt Securities's portfolio in Q1 2026, its #34 holding.
- Sunbelt Securities first reported a position in AbbVie in Q4 2014 and has held it in 45 quarters since.
- Sunbelt Securities's AbbVie position peaked at $9.52M in Q4 2021.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.